Novel use of alpha-sympathomimetics having a 2-imidazoline structure

Details for Australian Patent Application No. 2005291603 (hide)

Owner Merck Patent GmbH

Inventors Koelsch, Stephan; Sacher, Fritz; Tschaikin, Marion

Agent Davies Collison Cave

Pub. Number AU-B-2005291603

PCT Pub. Number WO2006/037452

Priority 10 2004 049 008.2 05.10.04 DE

Filing date 16 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 14 October 2010

International Classifications

A61K 31/4174 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/037452 Priority application(s): WO2006/037452

14 October 2010 Application Accepted

  Published as AU-B-2005291603

10 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005291607-Device for the continuous lengthening of a metal strip by traction, and method for operating one such device

2005291587-Aluminophosphate molecular sieve, its synthesis and use